Logo
International Journal of
Research in Pharmacy and Pharmaceutical Sciences
ARCHIVES
VOL. 5, ISSUE 4 (2020)
Emphasis on distinctive treatment approaches for rheumatoid arthritis in India
Authors
Shaik Ayesha Ameen, Koppula Jyothi, Babitha Angaluri
Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology categorised by a symmetric, peripheral polyarthritis, that is a frequent form of chronic inflammatory arthritis and often leads to joint destruction and physical disability. Since it is a systemic disease, it can lead to additional joint manifestations, including fatigue, subcutaneous nodules, lung involvement, pericarditis, peripheral neuropathy, vasculitis, and hematologic abnormalities. The objective of treatment is to minimise joint pain and inflammation, prevent radiographic damage and visible deformity, continue of work and personal activities. Joint resuscitation is indicated for patients with severe joint damage whose symptoms are not properly controlled by medical management. The last two decades have seen significant improvements in RA results. Historical descriptions of RA are currently less frequently encountered. Much of this progression can be traced to an expanded therapeutic arsenal and early treatment intervention. The change in treatment strategy dictates a new mind-set for primary care practitioners namely, one that demands early referral of patients with inflammatory arthritis to a pre-existing rheumatologist for prompt diagnosis and initiation of therapy. Only then will patients achieve their best results.
Download
Pages:47-51
How to cite this article:
Shaik Ayesha Ameen, Koppula Jyothi, Babitha Angaluri "Emphasis on distinctive treatment approaches for rheumatoid arthritis in India". International Journal of Research in Pharmacy and Pharmaceutical Sciences, Vol 5, Issue 4, 2020, Pages 47-51
Download Author Certificate

Please enter the email address corresponding to this article submission to download your certificate.